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Abstract
Preimplantation embryo development follows a series of critical events. Remarkable 
epigenetic modifications and reprogramming of gene expression occur to activate the 
embryonic genome. In the early stages of preimplantation embryo development,  maternal 
mRNAs direct embryonic development. Throughout early embryonic  development, 
a  differential methylation pattern is maintained although some show stage‐specific 
changes. Recent studies have shown that differential demethylation process results in 
differential parental gene expression in the early developing embryos that may have an 
impact on the correct development. In the recent years, noncoding RNAs, long  noncoding 
RNAs (lncRNA) and short of mRNAs and therefore their role in preimplantation devel‐
opment has gained significance.
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1. Introduction
Preimplantation embryo development follows a series of critical events. These events start 
at gametogenesis, formation of mature gametes, and lasts until parturition. Male and female 
gametes are derived from primordial germ cells (PGCs) by the processes of spermatogenesis 
and oogenesis, respectively. PGCs have unique properties of gene expression, epigenetics, 
morphology and behaviour. Once the PGCs undergo mitosis, spermatogenesis and oogenesis 
progress differently. In spermatogenesis, spermatogonia undergo mitosis starting at puberty 
until death and each primary spermatocyte produces four spermatids at the end of meiosis. 
In oogenesis, PGCs differentiate into oogonia, they enter meiosis and arrest until puberty. 
Unlike meiosis II in spermatogenesis, secondary oocyte does not complete meiosis II until 
fertilisation. With completion of meiosis II, each oogonia produce a single viable oocyte [1].
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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At fertilisation, the oocyte completes meiosis and the fertilised oocyte is called the zygote. 
Oocyte and sperm nuclei fuse resulting in syngamy (Figure 1). The zygote undergoes a 
series of cleavage divisions, forming two‐cell, four‐cell, eight‐cell morula and  blastocyst 
stages [2] (Figure 1). During cleavage stage divisions, programming of maternal and  paternal 
 chromosomes takes place to create the embryonic genome (embryonic genome activation, 
EGA) and to start the preimplantation embryo development. If the EGA fails, the  development 
does not continue because of the inability of the embryo to have cellular functions [3]. This 
activation is initiated by the degradation of maternal nucleic acids, specific RNAs stored in 
oocytes, proteins and other macromolecules [4]. Upon EGA, which starts at the two‐cell stage 
in mouse and four‐ to eight‐cell stage in human [5], remarkable reprogramming of expres‐
sion occurs in the preimplantation embryo. These reprogramming events are controlled by 
DNA methylation, histone acetylation, transcription, translation and miRNA regulation [6]. 
Therefore, the development of preimplantation embryos includes continuous molecular, cel‐
lular and morphological events. These events would eventually form a multilineage embryo 
that has a capability to implant and continue the foetal development.
In this chapter, different factors affecting gene expression during preimplantation embryo 
development will be discussed. Epigenetic factors, focusing on methylation profiles, of gam‐
etes and preimplantation embryos will be reviewed. The effects of noncoding RNAs on gene 
expression will be thoroughly evaluated.
2. Gene expression and epigenetics
For a normal developing embryo, the expression of both maternal and paternal genes is 
required. An intense epigenetic change occurs upon fertilisation to establish pluripotency [7]. 
Although there are a number of post‐translational modifications within chromatin including 
acetylation, ubiquitination, SUMOylation and phosphorylation; methylation of histone lysine 
and arginine residues is the main focus in preimplantation embryos.
Methylation and chromatin modification not only play crucial roles in determining the 
transcriptional state but also are capable of determining the transcriptional repression 
Figure 1. Schematic diagram outlining the main stages of preimplantation embryo development. Fertilisation followed 
by syngamy, cleavage divisions results in two, three, four, and so on cell embryos which eventually form the morula 
and the blastocyst.
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[8–10]. The mechanism leading to the changes in methylation is not well established, but it 
has been suggested that the reprogramming takes place by either passive or active demeth‐
ylation. Indirect pathways of demethylation are associated with DNA repair [11–14]. Two 
main stages, PGCs and preimplantation embryos, are important in the regulation by 
methylation.
2.1. Epigenetic modification of the zygote and the preimplantation embryos
In mammals (human, bovine, rat, pig and mouse), the zygote undergoes genome‐wide 
demethylation [15–17] with the exception of imprinted genes [18]. The male pronucleus of 
the zygote undergoes selective demethylation due to the loss of DNA replication leading to 
asymmetric methylated sister chromatids [15, 16, 19, 20]. These events start following the 
sperm decondensation in humans and in mouse with some variations [17, 21, 22]. The female 
pronucleus of the zygote remains highly methylated at this stage [17, 21, 22]. Demethylation 
of the maternal genome starts with the first cleavage divisions [19, 23, 24]. By the morula 
stage, the mouse preimplantation embryos become undermethylated. Polarisation and com‐
paction of individual blastomeres start at around eight‐cell stage of the developing embryo. 
Many factors are involved in these processes including E‐cadherin (CDH1), partitioning 
defective homologue 3 (PARD3), PARD6B and protein kinase C zeta [25–27].
The blastocyst stage embryo has a fluid‐filled cavity and two cell populations consisting 
of inner cell mass (ICM) and trophectoderm (TE). All the blastomeres are believed to be 
totipotent in cleavage embryos until four‐ to eight‐cell stage since these cells form both the 
ICM and TE lineage [28]. ICM develops into epiblast, whereas TE forms the extraembry‐
onic  tissues such as placenta. ICM is composed of pluripotent cells that have the capacity 
to develop into any cell type of the foetus. Transcriptional and epigenetic events strictly 
regulate these differentiation events. A number of transcriptional factors play a crucial role 
in blastocyst formation. These include caudal type homeobox 2 (CDX2) for TE specification, 
octamer 3/4 (OCT4) and NANOG for the establishment of ICM pluripotency [29–31]. CDX2 
is extensively expressed in eight‐ and 16‐cell stage and it is expressed only in TE cells of the 
blastocyst [32]. Although OCT4 and NANOG are also expressed broadly at eight‐ and 16‐cell 
stage embryos, they are only expressed in ICM in blastocysts [32]. A number of transcription 
factors are required for blastocyst formation. Embryos lacking CDX2 expression cannot form 
blastocoel cavity but they have the ability to implant [30]. Lack of OCT4 or NANOG expres‐
sion causes failure of ICM and the development of these embryos is arrested at the blastocyst 
stage [31, 32]. TEAD4 is another transcription factor that has a role in blastocyst transition in 
which the lack of TEAD4 nuclear localisation impairs TE‐specific transcriptional programme 
in inner blastomeres [33]. Furthermore, the aberrant expression of TCFAP2C transcription 
factor also leads to embryonic arrest during morula to blastocyst transition [34] and Klf5 
mouse‐mutant embryos arrest at the blastocyst stage [35].
The remethylation process starts shortly after implantation [16, 22, 23, 36]. This de novo 
methylation occurs asymmetrically, such that ICM is hypermethylated possibly due to the 
Dnmt3b methylase [37], whereas TE remains hypomethylated due to the active demethyl‐
ation by enzyme catalysis and passive demethylation [11, 14, 22]. Alteration of the methyla‐
tion profiles in embryos has been shown to cause alterations of ICM and TE differentiation. 
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Variations of the H3 arginine 26 residue (H3R26me) were shown to lead to changes of TE and 
ICM differentiation of a blastomere [38].
X‐chromosome inactivation is an epigenetic phenomenon in which the activity of X chromo‐
somes is strictly regulated to equalise X‐chromosome expression and gene dosage between 
males and females and relative to autosome chromosomes [39]. For correct development, 
 X‐chromosome dosage compensation is crucial. The inactivation of X chromosome occurs in 
at least two phases: initiation and maintenance. X‐inactivation mouse model systems have 
shown that the inactivation of X chromosome takes place during early embryogenesis of the 
female embryo by undergoing transcriptional silencing of genes along the X chromosome 
[40]. In human preimplantation embryos, it has been shown that the reduced expression of 
X chromosomes in females ensures the dosage compensation [41]. LncRNA XIST expres‐
sion activates the X‐chromosome inactivation by engaging proteins functioning in chromatin 
remodelling [3, 42]. With the advanced technologies, including single‐cell RNA sequencing, 
it has emerged that lncRNAs XACT and XIST are expressed on the active X chromosome 
in the early human preimplantation embryos [43]. Furthermore, the expression of these 
two RNAs has never been shown to overlap. Introducing XACT into heterologous systems 
caused the accumulation of Xist RNA in cis and therefore it may be involved in the control 
of XIST association to chromosome in cis and may temper its ability of silencing. It is also 
possible that XACT functions in balancing the X‐chromosome inactivation at the early stages 
of  preimplantation embryo development [43, 44]. Recently, the dosage compensation was 
shown to be driven by a CAG promoter of a new Xist allele (Xist(CAG)) [45]. Furthermore, 
Xist(CAG) upregulation in preimplantation embryos showed variation depending on the 
parental origin and the paternal expression was suggested to be preferentially inactivated 
with the paternal Xist(CAG) transmission [45].
2.2. Epigenetic modification of the gametes
In germ cells, methylation is maintained in a sex‐specific manner. Methylation in PGCs dimin‐
ishes as they migrate to the gonads. Studies suggest that in females, remethylation occurs 
after birth when the oocytes are in the process of development. When demethylation is com‐
pleted, the PGCs either enter mitosis in males or arrest at meiosis in females [46].
Reprogramming of the methylation in the embryo is necessary for parent‐specific expression 
of genes [14]. Gene expression varies during preimplantation embryo development due to 
these reprogramming events and appropriate gene expression determines the survival of the 
embryo [6]. Recently, short noncoding RNAs, microRNAs (miRNAs) and long noncoding 
RNAs (lncRNA) have gained importance in their potential function to affect numerous path‐
ways by targeting multiple genes [47, 48].
3. Gene expression and small noncoding RNAs: microRNAs
MiRNAs are a large family of short noncoding RNAs between 17 and 25 nucleotides (nt) 
in length [49]. MiRNAs were first identified in Caenorhabditis elegans over two decades ago 
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[50] and since then many have been identified in multiple organisms, such as worms, flies, 
fish, frogs, mammals and plants, by molecular cloning and bioinformatics [51]. Most miRNA 
sequences are conserved among a wide range of mammalians [52], though there are some 
that differ from each other only by a single nucleotide [53]. The conserved miRNA sequences 
among different species can be distinguished by the nomenclature such that when only the 
first three letters differ this indicates the same sequence in different species, that is, hsa‐
miR‐145 in Homo sapiens and mmu‐miR‐145 in Mus musculus [54].
MiRNAs have been shown to be of great importance in a wide variety of biological  processes 
involving cell cycle regulation, apoptosis, cell differentiation, imprinting, homeostasis and 
development, including limb development [55], morphogenesis of lung epithelial [56], 
embryonic angiogenesis [57], formation of hair follicle and proliferation of T‐cell [58, 59]. 
They play key roles in regulating transcriptional and post‐transcriptional gene silencing in 
many organisms by targeting mRNAs for translational inhibition, cleavage, degradation or 
destabilisation [53, 60–64]. Each miRNA has multiple mRNA targets that may regulate up 
to 30% protein‐coding genes and shape protein production from hundreds to thousands of 
genes [65–67]. MiRNAs recognise their targets through base pairing of the complementary 
sequence of their seed sequence (2–8 nt of miRNAs) within the open reading frame (ORF) and 
3′untranslated region (UTR) of target mRNA [68]. Although the targets of miRNAs are not 
fully known, bioinformatics studies show a range of possible target genes [69]. The functional 
activities and the predicted/observed targets of miRNAs can be identified using miRNA 
 databases. These databases can be accessed using the following URL: (http://www.targetscan.
org/, http://www.microrna.org/microrna/home.do and http://mirdb.org/miRDB/).
3.1. MiRNA biogenesis
MiRNA biogenesis involves multiple important steps. MiRNAs are first transcribed from 
genomic DNA into primary miRNA (pri‐miRNA), which contains a stem‐loop structure, by 
RNA polymerase II. These pri‐miRNAs are then processed by Drosha, which is a 30–160 kDa 
protein with one dsRNA‐binding and two catalytic domains [70]. In the presence of DGCR8, 
both strands of the hairpin are cut generating a pre‐miRNA product of approximately 70 nt 
in size [71]. These pre‐miRNAs are carried from the nucleus into the cytoplasm by Exportin‐5 
(Exp5), which is a nucleocytoplasmic transporter in karyopherin family that has binding 
sites for pre‐miRNAs in the presence of RAs‐related nuclear protein (Ran) and  guanosine 
 triphosphate (GTP) [72, 73]. These miRNAs are further cleaved by cytoplasmic RNase 
 endonuclease, Dicer, making 21–22 nt double‐stranded structure. Although one of the strands 
is usually degraded, both strands of the pre‐miRNA may be associated with Argonaute 
(Ago)‐protein‐containing complex and they are mediated by RISC/miRNP  (RNA‐induced 
silencing complex/mi‐ribonucleoprotein) to form single‐stranded mature miRNAs. MiRNAs 
associated with RISC mainly target mRNAs and they either inhibit their translation or cause 
degradation of mRNA that results in reduced protein synthesis [70, 74].
Studies showed that processing of miRNAs by Dicer was vital and any defects, such as deletion 
of Dicer in the developing animals, caused aberrations [75, 76]. Lack of Dicer in Drosophila 
germ line stem cells postponed the G1/S phase transition [77], suggesting that miRNAs may 
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be vital for stem cells to bypass this checkpoint. Reduced and disorganised spindles, incor‐
rect chromosome alignment and defects in gastrulation were observed with the Dicer‐mutant 
oocytes in mouse and in C. elegans, respectively [50, 78]. Injection of miR‐430 in zebrafish and 
C. elegans partially repaired the gastrulation, retinal development and somatogenesis [78]. 
Dicer deletion in zebrafish, mouse and hippocampal initiated problems in the nervous sys‐
tem and led to the inability of forming mature miRNAs that resulted in variations of brain 
morphogenesis and differentiation of neurons [79, 80]. Although the axis formation and early 
differentiation of maternal‐zygotic Dicer‐mutant zebrafish and mouse embryos were normal, 
they still triggered defects in somitogenesis, morphogenesis that affected the brain formation, 
gastrulation, heart development and apoptosis in limb mesoderm, respectively [78, 81–83]. 
Apoptosis was enhanced in the developing limb mesoderm of Dicer null mouse [84]. Dicer 
deficiency mainly led to embryo death in mouse around embryonic day 7.5 [50, 78, 85] and in 
zebrafish [86] that may indicate the importance of miRNA‐mediated gene silencing at mater‐
nal to zygotic transition.
Complete loss of Dicer1 in somatic cells of mouse reproductive tract not only showed reduced 
expression of miRNAs but also caused the female mice to become infertile with compromised 
oocyte and embryo integrity [50, 87]. Dicer‐deficient male mice were shown to have poor prolif‐
eration of spermatogonia. Loss of Dicer1 in the germ line of male mice (homozygote Dicer1) led 
to decreased fertility due to abnormal spermatogenesis. The number of germ cells was reduced 
with abnormal spermatids, abnormal phenotype of spermatocytes with condensed nucleus, 
abnormal sperm motility and mutant testes with Sertoli tubules [88]. Studies suggest that the 
transfer of maternal cytoplasmic Dicer disguised the early abnormal phenotypes [78, 89].
Knock‐out of Ago2 in mouse embryonic fibroblasts and haematopoietic cells caused decreased 
levels of mature miRNAs [61, 90, 91]. Ago2‐deficient oocytes were observed to develop the 
mature oocytes with abnormal spindles and chromosomes were not able to unite properly 
with reduced expression levels of miRNAs (more than 80%). Loss of Ago2 function leads to 
embryo death around embryonic day 9.5 in mouse [92].
3.2. Expression of miRNAs in preimplantation embryos
The expression of miRNAs in preimplantation embryos has been mainly studied by knock‐
out experiments, by cloning experiments and by identifying individual miRNAs by microar‐
ray analysis and real‐time polymerase chain reaction [93]. The expression studies have been 
carried out using animal models and tissues, cultured cells; that is, cancer cells and human 
embryonic stem cells; and mouse/bovine/human gametes and embryos. Human embryonic 
stem cells, which are derived from the inner cell mass of an embryo at the blastocyst stage 
and are characterised by their ability of self‐renewal and multipotency, are the key in gene 
expression research since the access of human embryos is difficult and these cells are one of 
the closest representations of human embryos. Studying miRNA expression in stem cells not 
only gives insight into potential miRNAs expressed in human embryos but also may show the 
important role of miRNAs in the stem cell functioning [94].
MiRNA expression has been observed as early as oogenesis and spermatogenesis in mouse, 
bovine and human [95, 96]. Differences in the miRNA expression have been observed between 
Embryo Cleavage70
immature and mature oocytes that may represent the natural turnover and indicate that 
each embryonic stage is defined by a specific miRNA. Similar miRNA expression profiles in 
mature mouse oocytes and early developing embryos indicate that at these stages the zygote 
has maternally inherited miRNAs [50]. Similar to oocyte, sperm carries a range of miRNAs. 
Approximately 20% of these miRNAs are located in the nuclear or perinuclear part of the 
sperm indicating that these miRNAs are transferred to the zygote at the time of fertilisation 
[97]. It was suggested that the sperm‐borne miRNAs may down‐regulate the maternal tran‐
scripts in mammals. However, when this hypothesis was tested using microarray analysis, it 
was shown that none of these miRNAs in the sperm have significant importance since all of 
them were already present in the oocytes (meiosis II) [98].
Multiple miRNAs were involved in the formation of germ cell layers. MiR‐290, which was 
expressed at different levels during preimplantation embryo development of mouse embryos, 
had a negative effect on the germ cell and mesoderm differentiation in the mouse ES cells via 
targeting Nodal inhibitors [99]. In zebrafish, however, miR‐290 cluster played an important 
role in regulating the mesoderm induction [100]. Therefore, it is not clear if miR‐290 has an 
inhibitory effect on the mesoderm differentiation. Other miRNAs have been shown to have an 
effect in mesoderm differentiation in zebrafish, such as miR‐15 and miR‐16 [100], which were 
also expressed in mouse preimplantation embryos [50].
Mainly, the same miRNAs are expressed during the cleavage divisions of the embryo in 
mouse and bovine. However, their expression levels often vary during these stages. In murine 
embryos, the level of miRNA expression is reduced by as much as 60% between one‐ and two‐
cell stages. At the end of four‐cell stage, mouse embryos have approximately twice as much 
miRNA compared to the two‐cell stage embryo. This implies that the maternally inherited 
miRNAs degrade at this stage and the EGA starts between the one‐cell and four‐cell stages 
[50]. Even though the synthesis and degradation of miRNAs coexists during the preimplan‐
tation embryo development in mice, the overall miRNA expression increased towards the 
blastocyst stage [101].
More than 700 miRNAs have been identified in humans [87, 95, 96, 102]. The level of expres‐
sion for the majority of these miRNAs stayed the same between the oocyte and the blastocyst 
stage [87]. More than 50% of the miRNAs expressed in human oocytes and blastocysts were 
shown to be involved in tumourigenesis, that is, let‐7 family, miR‐19a, miR‐21 and miR‐34 
[103–109].
4. Gene expression and long noncoding RNAs
In the last few years, in addition to short noncoding RNAs, the lncRNA have gained impor‐
tance in their roles to affect gene expression. The mammalian genomes consist of long inter‐
genic noncoding RNAs (lincRNAs) that have been suggested to take a role in the regulation 
of pluripotency during preimplantation embryo development [110]. Human pluripotency 
transcripts 2, 3 and 5 (HPAT2, HPAT3 and HPAT5) were reported to adjust the pluripotency 
and ICM formation in preimplantation embryos. Furthermore, HPAT5 was shown to interact 
with let‐7 family of miRNAs [110].
Control of Embryonic Gene Expression and Epigenetics
http://dx.doi.org/10.5772/67851
71
Implantation of embryos involves complex mechanisms and many different genetic and 
physiological factors are involved during the process. Developing preimplantation embryo 
must have a good coordinated interaction with the maternal uterine endometrium. LncRNAs 
were shown to be differentially expressed in endometrial tissues obtained from pigs with 
pregnancy and non‐pregnancy with two lncRNAs, TCONS_01729386 and TCONS_01325501, 
with potential roles in implantation [111].
5. Gene expression and assisted reproductive technologies
In Western world, approximately 1% of children are born with assisted reproductive technol‐
ogy (ART) treatments. The infertile couples have the best possibility to conceive a child with 
these treatments. Although these techniques have been considered to be safe in terms of foetal 
and post‐natal development [112, 113], there is an increased risk for morbidities, especially 
imprinting disorders [114]. Furthermore, the global gene expression profiles vary due to in 
vitro culture of zygotes [115, 116] and in vitro fertilisation processes [117]. Following in vitro 
culture, apoptotic and morphogenetic pathways have shown to be altered [118].
Intra‐cytoplasmic sperm injection (ICSI), one of the widely used ART techniques, provides 
infertile couples with sperm motility problems a great chance to have a baby. ICSI is a unique 
process in which the sperm is injected into the ooplasm [119]. However, ICSI bypasses a 
 number of physiological processes that would normally take place. These embryos derived 
from ICSI were shown to be cleaved at a slower rate. Furthermore, a reduced number of 
embryos become hatched with a fewer number of cells and the calcium oscillations are shorter 
with different patterns [120]. Mice embryos generated by ICSI were shown to be obese and 
have anomalies of the organs [121].
6. Conclusion
Normal development of preimplantation embryos involves complex mechanisms. For a normal 
developing embryo, the expression of both maternal and paternal genes is required. Several 
factors are involved in the regulation of parental genes in preimplantation embryos. Epigenetic 
modifications are one of the most important factors that are involved in the regulation of gene 
expression during preimplantation embryos. Extensive research studies have been performed 
throughout the years to establish the methylation profiles of the mammalian gametes and 
embryos. In the more recent years, the importance of noncoding RNAs in the regulation of 
genes has become clear. A handful of studies have been performed to analyse the expression of 
microRNAs, which have been shown to regulate mRNAs that encode up to 30% human pro‐
tein‐coding genes. The expression of miRNAs has been observed in mouse, bovine and human 
gametes and embryos. Furthermore, in the last couple of years, expression of long noncoding 
RNAs and their roles in embryonic development and implantation have been investigated. 
The extensive research studies have provided crucial understanding of the development of 
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 preimplantation embryos and the regulation of gene expression, and with the advancing tech‐
nologies more molecular studies will help to comprehend the mechanisms better.
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